Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways (journal article) Scientific Reports, volume 14, issue 1 (2024). |
Real-World Evaluation of T-Prolymphocytic Leukemia Outcomes Using the 2019 T-PLL International Study Group Criteria (journal article) Blood, volume 142, issue Supplement 1, pages 6213-6213 (2023). |
Pathobiology and Targeting of CD38 in Cutaneous T-Cell Lymphoma (journal article) Blood, volume 142, issue Supplement 1, pages 1650-1650 (2023). |
Blood Advances, volume 7, issue 20, pages 6206-6210 (2023). |
Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia (journal article) Blood, volume 142, issue 15, pages 1271-1280 (2023). |
Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms (journal article) Blood Advances, volume 7, issue 14, pages 3637-3641 (2023). |
The role of interleukin-15 in the development and treatment of hematological malignancies (journal article) Frontiers in Immunology, volume 14 (2023). |
Blood, volume 140, issue Supplement 1, pages 9216-9218 (2022). |
Blood, volume 140, issue Supplement 1, pages 6381-6382 (2022). |
Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia (journal article) Blood Advances, volume 6, issue 8, pages 2685-2687 (2022). |
Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia (journal article) Frontiers in Oncology, volume 12 (2022). |
Survival Analysis of Patients with T-Cell Lymphoma or T-Cell Large Granular Leukemia and Concomitant Plasma Cell Dyscrasias (journal article) Blood, volume 138, issue Supplement 1, pages 2449-2449 (2021). |
Efficient Targeting of CD38 in Mature T-Cell Neoplasms with Daratumumab and Allogeneic NK Cells (journal article) Blood, volume 138, issue Supplement 1, pages 2408-2408 (2021). |
Cyclophosphamide Induces Durable Molecular and Clinical Responses in Patients with Relapsed T-Large Granular Lymphocytic Leukemia (T-LGLL) (journal article) Blood, volume 138, issue Supplement 1, pages 2471-2471 (2021). |
Differential Integrin Adhesome Expression Defines Human NK Cell Residency and Developmental Stage (journal article) The Journal of Immunology, volume 207, issue 3, pages 950-965 (2021). |
Journal of Clinical and Translational Science, volume 5, issue s1, pages 92-92 (2021). |
Clinical outcomes in T‐cell large granular lymphocytic leukaemia: prognostic factors and treatment response (journal article) British Journal of Haematology, volume 192, issue 3, pages 484-493 (2021). |
Role of Mir-29b in T-Cell Development and in Cutaneous T-Cell Lymphoma Pathogenesis (journal article) Blood, volume 136, issue Supplement 1, pages 37-37 (2020). |
Applied Genomics and Public Health Cancer Genomics (book chapter) In Applied Genomics and Public Health Elsevier (2020) |
Blood, volume 134, issue Supplement_1, pages 2835-2835 (2019). |